Protagenic Therapeutics, Inc. Board of Directors

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Dr. Robert Benjamin Stein M.D., Ph.D.

Dr. Robert Benjamin Stein M.D., Ph.D.

Chief Medical Officer & Director

Dr. Andrew Slee Ph.D.

Dr. Andrew Slee Ph.D.

Chief Operating Officer

Dr. Garo H. Armen Ph.D.

Dr. Garo H. Armen Ph.D.

Co-Founder & Executive Chairman of the Board

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.